Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia
NCT00593593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2008-10-15
Summary
This study has 4 phases: screening phase (visit 1), treatment phase (visit 2 - 6 mths after treatment initiation), and end of treatment phase (visit 3 - end of year 1). Only in the case a serious adverse event (SAE) arises, will there be a follow up phase (visit 4).
Conditions
- Benign Prostatic Hyperplasia
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
More Related Trials
-
Drug Use Investigation for AVOLVE(BPH)
NCT01376284 ·Status: COMPLETED
-
Prospective Sexual Function Study for BPH Subjects
NCT01777269 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
NCT01294592 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
NCT00537654 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence - Duodart Against Avodart & Omnic
NCT01657851 ·Status: COMPLETED ·Phase: PHASE1
-
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
NCT00421421 ·Status: TERMINATED ·Phase: PHASE4
-
The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
NCT01484808 ·Status: UNKNOWN
-
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy
NCT00593853 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
NCT00244309 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
NCT00431626 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
NCT00359905 ·Status: COMPLETED ·Phase: PHASE3
-
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
NCT00090103 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia
NCT01332487 ·Status: COMPLETED
-
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00701779 ·Status: COMPLETED ·Phase: PHASE4
-
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
NCT00375765 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
NCT01254071 ·Status: COMPLETED ·Phase: PHASE1
-
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
NCT00368979 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
NCT02184585 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
NCT02509104 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
NCT00866554 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
NCT00347061 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
NCT00970632 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
NCT02058368 ·Status: COMPLETED ·Phase: PHASE3
-
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
NCT00398281 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
NCT01435954 ·Status: COMPLETED